Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2008

Dec 5, 2008

34975_dirs_2008-12-05_1b8cc629-fa32-43ff-9999-cc1a5b3da01e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2008-12-03

Reporting Person: GREEN DAVID (Director, President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-12-03 Common Stock P 1400 $2.00 Acquired 1389673 Direct
2008-12-04 Common Stock P 100 $2.00 Acquired 1389773 Direct
2008-12-04 Common Stock P 9900 $1.97 Acquired 1399673 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-12-04 Stock Option (Right to buy) $1.99 A 200000 Disposed 2018-12-04 Common Stock, par value $0.01 per share (200000) Direct

Footnotes

F1: Purchased pursuant to a stock trading plan established in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2: The shares vest in four equal installments on each of the first four anniversaries of January 1, 2008.